These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26028072)

  • 1. Preventive effects of a major component of green tea, epigallocathechin-3-gallate, on hepatitis-B virus DNA replication.
    Karamese M; Aydogdu S; Karamese SA; Altoparlak U; Gundogdu C
    Asian Pac J Cancer Prev; 2015; 16(10):4199-202. PubMed ID: 26028072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
    He W; Li LX; Liao QJ; Liu CL; Chen XL
    World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro.
    Xu J; Wang J; Deng F; Hu Z; Wang H
    Antiviral Res; 2008 Jun; 78(3):242-9. PubMed ID: 18313149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
    Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro.
    He YW; Guo CX; Pan YF; Peng C; Weng ZH
    World J Gastroenterol; 2008 Mar; 14(10):1592-7. PubMed ID: 18330954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro.
    Pang JY; Zhao KJ; Wang JB; Ma ZJ; Xiao XH
    J Zhejiang Univ Sci B; 2014 Jun; 15(6):533-9. PubMed ID: 24903990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
    Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX
    World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.
    Gao YF; Yu L; Wei W; Li JB; Luo QL; Shen JL
    World J Gastroenterol; 2008 Aug; 14(29):4684-9. PubMed ID: 18698684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication.
    Zhong L; Hu J; Shu W; Gao B; Xiong S
    Cell Death Dis; 2015 May; 6(5):e1770. PubMed ID: 25996297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.
    Huang KL; Lai YK; Lin CC; Chang JM
    World J Gastroenterol; 2006 Sep; 12(35):5721-5. PubMed ID: 17007029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
    Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
    Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice.
    Lai YH; Sun CP; Huang HC; Chen JC; Liu HK; Huang C
    BMC Complement Altern Med; 2018 Sep; 18(1):248. PubMed ID: 30189898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-phase arrest after vincristine treatment may promote hepatitis B virus replication.
    Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL
    World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of microRNA let-7a positively correlates with hepatitis B virus replication in hepatocellular carcinoma tissues.
    Qiu D; Chen J; Liu J; Luo Z; Jiang W; Huang J; Qiu Z; Yue W; Wu L
    Exp Biol Med (Maywood); 2017 May; 242(9):939-944. PubMed ID: 28440732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
    Huang YQ; Wang LW; Yan SN; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
    Yan SN; Deng B; Gong ZJ
    Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of SAHA on proliferation and apoptosis of hepatocellular carcinoma cells and hepatitis B virus replication.
    Wang YC; Yang X; Xing LH; Kong WZ
    World J Gastroenterol; 2013 Aug; 19(31):5159-64. PubMed ID: 23964152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cells.
    Xin XM; Li GQ; Jin YY; Zhuang M; Li D
    World J Gastroenterol; 2008 Jun; 14(24):3849-54. PubMed ID: 18609708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
    Huang HC; Tao MH; Hung TM; Chen JC; Lin ZJ; Huang C
    Antiviral Res; 2014 Nov; 111():100-11. PubMed ID: 25260897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
    Hu K; Huang Y; Mu J; Cheng Z; Zhu X
    Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.